As the U.S. equities market starts the new year with a continued slump, investors are closely monitoring opportunities that might emerge amidst broader market challenges. Penny stocks, often ...
Semorinemab (RG-6100) was under development for the treatment of mild to moderate Alzheimer’s disease. The drug candidate is administered through intravenous route which acts by targeting tau protein.
This profile has not been claimed by the company. See reviews below to learn more or submit your own review. Carrier Heating & Cooling manufactures air conditioners, furnaces, heat pumps ...
Governor Kathy Hochul recently signed legislation that would require health insurance companies to cover the cost of scalp cooling systems for those fighting cancer. Around six years ago, Maureen ...